3PBIOVIAN is formerly owned by Keensight Capital, through Keensight Nova V, since 2020.

When did Keensight Capital acquire 3PBIOVIAN?

Keensight Capital acquired 3PBIOVIAN in 2020 and exited after 4 years.

Has 3PBIOVIAN been sold?

Yes. 3PBIOVIAN was exited in 2024 via MBO.

Home/Companies/TMT/3PBIOVIAN

3PBIOVIAN

TMT·

France·Exited 2024·Held 4yr

3PBIOVIAN is a technology company, headquartered in France.

Entry

2020

Hold

4yr

Exit

2024

Est. EV

–

Investor

Keensight Capital

Key facts

HQFrance

SectorTechnology

Biovian and 3P Biopharmaceuticals combined into 3PBIOVIAN under Keensight common ownership in February 2024 (per Keensight press release).…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Keensight Nova V

Other portfolio companies in the same fund.

More PE-backed in TMT

Comparable tmt deals from other GPs.

Last updated April 2026 · Sourced from public filings